疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

% M' ^. T5 ^) J1 k6 S$ N. I

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
: l$ X( P& d5 E  E' C& _
- t5 E+ \* u3 Zhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
) h$ Z8 i% g: v: n
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
# I' n* G$ y/ b/ X+ i/ a5 i  ^2 Vaccine immunology 14
3 The vaccine industry 33
4 h: q* [1 v: t8 J1 ~4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
* c2 y+ g) W6 \6 Vaccine additives and manufacturing residuals in the United States:
# B8 {1 p. M1 g9 o- t& k  wlicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
6 `" D1 @7 w" {+ \) |3 g# N4 S11 Cholera vaccines 141
; w! F2 j9 h. `9 k& X5 q' r12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
& J' l' g7 D% r1 D# e18 Influenza vaccine-live 294
9 n9 \. G  N# D' v- C! P19 Japanese encephalitis vaccines 312
/ A; |' t2 I8 w6 r8 F4 g20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
2 c/ L8 B  `  w  [24 Plague vaccines 493
6 Q/ Y+ q+ O7 O: F6 ~# }7 T" L25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
7 g# n! A% m# I5 T. d27 Poliovirus vaccine-inactivated . 573
* A* N! Z1 x& w% g% u/ j' G, a& |28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
, b- k* {. w2 ]* c* W8 T/ ?30 Rotavirus vaccines . 669
31 Rubella vaccine 688
7 Y$ k# \% G4 ]0 {0 R, q; k32 Smallpox and vaccinia 718
6 a$ ^; L5 ]6 p8 V' G33 Tetanus toxoid 746
, \5 v1 M5 j+ x& W34 Tick-borne encephalitis virus vaccines 773
, L' U$ C1 p  V6 V8 L: q; T0 J35 Tuberculosis vaccines 789
1 x5 q2 n5 i$ O  n; N36 Typhoid fever vaccines 812
37 Varicella vaccine 837
+ M9 I+ P; V- i7 o) w38 Yellow fever vaccine 870
* l9 \& s) n0 n$ h5 Y2 f; z9 D39 Zoster vaccine 969
* n0 X+ L+ _% p; r; d40 Combination vaccines 981
: T! E2 ?. c9 s7 c- CSECTION 3: Vaccines in development and new vaccine strategies
' H+ C9 o) P% ~; I+ O41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
! a; k% I2 A5 ^$ N4 o; m43 Cytomegalovirus vaccines 1032
! l1 {, R, k8 a/ I% {, ^& q44 Dengue vaccines 1042
8 S& {9 j7 s$ L4 d, v* G8 z& V- @45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
) a9 s' g% ~6 f1 |3 k, m47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
' U" M. E: ]8 ~' W' Z49 Hepatitis E vaccines 1085
' l8 o. v( t! K- c2 f4 ^50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
. W6 s1 p' S/ |52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
, M' L3 s; w' I$ q9 e' Y54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
2 v  \9 q. ?# G' R; C56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
+ p5 m" E% |5 i. n" t  h& W5 ?58 Streptococcus group A vaccines 1169
' K0 l8 ?! q3 }' y1 z( L+ ?59 Streptococcus group B vaccines 1176
% g0 V7 O% ^: V  P  Y; M( k1 A60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
; g- l* a* q$ p' k" h* v7 @62 The development of gene-based vectors for immunization 1232
0 x4 T, Z8 B' x6 y8 `' uSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
7 W6 D. u5 a7 c: z0 {64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
/ m/ S, p1 d% M+ e; O: n66 Vaccines for health care personnel 1290
3 n- ]# G) m. m( RSECTION 5: Public health and regulatory issues
" t: \. o+ q! s( |" i' u; F2 b$ i! [1 W67 Immunization in the United States 1310
; s2 e# |& Q- s3 m68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
! t  J+ C2 }6 p70 Immunization in developing countries 1369
71 Community immunity 1395
+ G' Q& s9 w& b, w5 i+ w72 Economic analyses of vaccine policies 1413
3 g) Q: V% m% K3 h" R, U73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
& @5 H2 I: @0 S6 y6 Q  K" j  E
& M0 R4 P1 d. E: g) S
; M9 b$ G& O9 y8 h( t- L+ z$ d2 o

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

' O* t  }& U3 A7 w4 ?! n# _Vaccines, 6th Edition
" ^+ J3 L, T: a1 u. V& N
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606
( \$ m4 ?* m3 ~) m- t: ?
SECTION 1: General aspects of vaccination
7 T1 ?) i1 z6 M6 Q' e- H1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 W- Z* y( b9 ~# P4 Vaccine manufacturing 44
! `* u& \0 y5 }3 K' G4 X5 Evolution of adjuvants across the centuries 58
4 q' ?2 ?8 M3 H' W7 l6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
0 v/ Z$ e/ f  d( Q$ Y. P) l7 Passive immunization 80
8 General immunization practices 88
: `" t1 J9 @' c: k8 A: O0 ~SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
( Y0 l0 m, D. A1 W& l10 Anthrax vaccines 127
11 Cholera vaccines 141
6 o' _9 o1 \+ r+ p( \12 Diphtheria toxoid 153
! K/ P# O' H" p& G9 E0 x, N13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
! Y$ L3 S" |8 l( w1 g16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
5 L6 Z9 o3 R* t" V+ o20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
5 ]% T. [8 B& Z* P( I23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
. [. v! \8 l! v% E0 `7 d28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
0 j! {6 J7 O, O! z. k31 Rubella vaccine 688
" P# g+ B& X: E3 a32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
' k3 F3 j1 q1 w" n: d& J5 L37 Varicella vaccine 837
0 \) {6 R3 v8 e$ l4 j4 S' P38 Yellow fever vaccine 870
7 m; _+ X6 |' t: ~/ H39 Zoster vaccine 969
40 Combination vaccines 981
" J7 a  `2 _: dSECTION 3: Vaccines in development and new vaccine strategies
! w6 Z9 X) S$ u8 \# c41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
- V2 y' [$ O& u4 V43 Cytomegalovirus vaccines 1032
- L' G3 F3 c8 ~! Y44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
0 e0 _% Z. A& H( C0 u; I* \+ J49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
& y( z! b9 K" v9 r5 w51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
5 Q* S+ V6 b; [$ _2 I55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
+ j" d/ W# o- a+ |# R57 Staphylococcus aureus vaccines 1161
; C- n+ U/ {* X58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
: [1 J1 ~, `) S2 U3 I. I62 The development of gene-based vectors for immunization 1232
. H. O0 U' O- M  ISECTION 4: Vaccination of special groups
9 ~! A2 i. P/ Z# _0 l63 Vaccination of immunocompromised hosts 1243
' [4 l. x1 h0 q/ x5 L5 \64 Vaccination of human immunodeficiency virus-infected persons 1257
6 e8 x6 A, |) ]$ E8 p( _0 t/ M65 Vaccines for international travel 1270
5 o2 X0 K( m" b& l2 l66 Vaccines for health care personnel 1290
) m- L: M: |2 F- ]# dSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
' f) V/ W+ d, F" \! v+ _69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
0 J& ~# M2 @4 I" u5 H( J7 b71 Community immunity 1395
) H' Z6 l7 z0 L+ M7 R9 A72 Economic analyses of vaccine policies 1413
( a' `+ d  j: v1 C( M) s73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
7 H& \. e: m, J- @9 }* m5 [& Q5 HPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
& w6 R( O7 n$ `ISBN-10: 1455700908
# T5 H. _2 _; f3 Y0 n. ?" _0 fSize: 52.3mb (original pdf)

2013 BMA Medical Book Awards Highly Commended in Public Health!
4 Z" M* d- d, E1 t! \Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
& a& j- G& `# R1 y" Z3 PGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
7 a5 E; W: w5 u6 ]Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
" [9 [, Z7 z: Q+ A# tPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
$ T- Z* `& T% O# U" YMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
9 p" Q9 E4 C% {4 x4 S) m6 Q
Download link: http://pan.baidu.com/s/1i5NxwLR
7 i( P' r+ y# N: m7 r8 F, ?Code for downloading: dv96